Table 1 Clinical characteristics and rest echocardiographic parameters in the propensity score matched patients
Variables | Abnormal ESE (n = 51) | Normal ESE (n = 51) | p-values |
|---|---|---|---|
Clinical characteristics | |||
Age (years) – mean (SD) | 66.4 (8.7) | 65.1 (9.4) | 0.49 |
Female sex – no. (%) | 20 (39.2) | 18 (35.3) | 0.84 |
Hypercholesterolemia – no. (%) | 31 (60.8) | 27 (53.0) | 0.55 |
Hypertension – no. (%) | 31 (60.8) | 26 (51.0) | 0.43 |
Diabetes mellitus – no. (%) | 12 (23.5) | 9 (17.7) | 0.63 |
Current smoker – no. (%) | 14 (27.5) | 13 (25.5) | 1.00 |
Prior hemodynamically significant CADa – no. (%) | 13 (25.5) | 14 (27.5) | 1.00 |
Medications at time of ESE | |||
Beta-blocker – no. (%) | 12 (23.5) | 10 (19.6) | 0.81 |
ACE inhibitor/ARB – no. (%) | 25 (49.0) | 18 (35.3) | 0.23 |
Calcium channel blocker - no. (%) | 15 (29.4) | 6 (11.8) | 0.05 |
Long-acting nitrate - no. (%) | 3 (5.9) | 3 (5.9) | 1.00 |
ESE parameters at rest | |||
Left ventricular ejection fraction at rest – median (IQR) | 55.0 (55.0–60.0) | 55.0 (55.0–60.0) | 0.77 |
Presence of ≥ 1 regional wall motion abnormalities at rest – no. (%) | 15 (29.4%) | 4 (7.8%) | 0.005 |
Wall motion score index at rest – median (IQR) | 1.0 (1.0 – 1.1) | 1.0 (1.0 – 1.0) | 0.008 |